Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03762681
What this trial is testing

RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B Virus Infection
Hoffmann-La Roche 55
Early research (Phase 1)Looking for participantsNCT07229911
What this trial is testing

TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Healthy VolunteersPrimary Sclerosing Cholangitis
Takeda 134
Early research (Phase 1)Study completedNCT04389775
What this trial is testing

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Who this might be right for
Type 2 Diabetes MellitusObesityNonalcoholic Steatohepatitis
Sciwind Biosciences APAC CO Pty. Ltd. 64
Testing effectiveness (Phase 2)Study completedNCT01710501
What this trial is testing

Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Who this might be right for
Chronic Hepatitis C (CHC)
Merck Sharp & Dohme LLC 87
Large-scale testing (Phase 3)Ended earlyNCT06488911
What this trial is testing

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Who this might be right for
Primary Biliary Cholangitis
Intercept Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT00863239
What this trial is testing

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 116
Early research (Phase 1)Study completedNCT05560607
What this trial is testing

Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicNAFLD+3 more
AstraZeneca 19
Early research (Phase 1)Active Not RecruitingNCT04046445
What this trial is testing

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal CancerMSSStage IV Colon Cancer+3 more
Amal Therapeutics 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Very early researchLooking for participantsNCT06310291
What this trial is testing

VTP-1000 in Adults With Celiac Disease

Who this might be right for
Celiac Disease
Barinthus Biotherapeutics 45
Testing effectiveness (Phase 2)Study completedNCT00546715
What this trial is testing

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 95
Early research (Phase 1)Study completedNCT02908191
What this trial is testing

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 86
Testing effectiveness (Phase 2)Study completedNCT02856555
What this trial is testing

Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 127
Early research (Phase 1)Study completedNCT00971308
What this trial is testing

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 37
Testing effectiveness (Phase 2)Looking for participantsNCT07325526
What this trial is testing

Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Who this might be right for
Liver Cirrhosis
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Study completedNCT04856085
What this trial is testing

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Vir Biotechnology, Inc. 244
Early research (Phase 1)Study completedNCT04137055
What this trial is testing

Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics

Who this might be right for
Nonalcoholic Steatohepatitis
Guangdong Raynovent Biotech Co., Ltd 104
Early research (Phase 1)Study completedNCT00576589
What this trial is testing

Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones

Who this might be right for
Obesity
Pfizer 41
Early research (Phase 1)UnknownNCT04615312
What this trial is testing

A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors

Who this might be right for
Digestive System Tumors
Henan Cancer Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04328077
What this trial is testing

LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 101
Next Page